237 related articles for article (PubMed ID: 25367185)
1. Autophagy and haematopoietic stem cell transplantation.
Leveque L; Le Texier L; Lineburg KE; Hill GR; MacDonald KP
Immunol Cell Biol; 2015 Jan; 93(1):43-50. PubMed ID: 25367185
[TBL] [Abstract][Full Text] [Related]
2. [Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].
Fu HX; Zhang XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):222-6. PubMed ID: 18315936
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation.
Smith P; O'Sullivan C; Gergely P
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934113
[TBL] [Abstract][Full Text] [Related]
4. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Autophagy in Hematopoietic Stem Cell Transplantation.
Montazersaheb S; Ehsani A; Fathi E; Farahzadi R; Vietor I
Front Bioeng Biotechnol; 2022; 10():849768. PubMed ID: 35677295
[TBL] [Abstract][Full Text] [Related]
6. Association between thymic function and allogeneic hematopoietic stem cell transplantation outcome: results of a pediatric study.
Saglio F; Cena S; Berger M; Quarello P; Boccasavia V; Ferrando F; Pittana L; Bruno B; Fagioli F
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1099-105. PubMed ID: 25708218
[TBL] [Abstract][Full Text] [Related]
7. Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation.
Guan Q; Blankstein AR; Anjos K; Synova O; Tulloch M; Giftakis A; Yang B; Lambert P; Peng Z; Cuvelier GD; Wall DA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1205-14. PubMed ID: 25963921
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.
Yeh AC; Brunner AM; Spitzer TR; Chen YB; Coughlin E; McAfee S; Ballen K; Attar E; Caron M; Preffer FI; Yeap BY; Dey BR
Biol Blood Marrow Transplant; 2014 May; 20(5):730-4. PubMed ID: 24530972
[TBL] [Abstract][Full Text] [Related]
10. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients.
Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T
Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893
[TBL] [Abstract][Full Text] [Related]
11. Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease.
Cuthbertson P; Geraghty NJ; Adhikary SR; Bird KM; Fuller SJ; Watson D; Sluyter R
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361109
[TBL] [Abstract][Full Text] [Related]
12. Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.
Pilon S; Jedrysiak D; Sheppard D; Bredeson CN; Tay J; Allan DS
Biol Blood Marrow Transplant; 2015 Feb; 21(2):364-70. PubMed ID: 25445635
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
14. Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies.
Xiong Y; Bensoussan D; Decot V
Transfus Med Rev; 2015 Oct; 29(4):259-67. PubMed ID: 26282736
[TBL] [Abstract][Full Text] [Related]
15. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
[TBL] [Abstract][Full Text] [Related]
16. Humoral Immune Reconstitution Kinetics after Allogeneic Hematopoietic Stem Cell Transplantation in Children: A Maturation Block of IgM Memory B Cells May Lead to Impaired Antibody Immune Reconstitution.
Abdel-Azim H; Elshoury A; Mahadeo KM; Parkman R; Kapoor N
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1437-1446. PubMed ID: 28495643
[TBL] [Abstract][Full Text] [Related]
17. Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?
Dickinson AM; Norden J
Int J Immunogenet; 2015 Aug; 42(4):229-38. PubMed ID: 26010044
[TBL] [Abstract][Full Text] [Related]
18. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation.
Broen K; van der Waart AB; Greupink-Draaisma A; Metzig J; Feuth T; Schaap NP; Blijlevens NM; van der Velden WJ; Dolstra H
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1443-9. PubMed ID: 21763254
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
